COMPARATIVE ASSESSMENT OF GEFITINIB AND ERLOTINIB THERAPY IN SUBJECTS WITH NON-SMALL CELL LUNG CARCINOMA. International Research Journal of Pharmacy, [S. l.], v. 14, n. 9, p. 1–5, 2023. Disponível em: https://irjponline.org/index.php/irjp/article/view/64. Acesso em: 30 may. 2026.